|
BioSpecifics
Technologies Corp
|
Nasdaq:BSTC
BioSpecifics Technologies
Corp. (BT Corp.) is engaged in the business of producing and licensing
for sale a fermentation derived enzyme named Collagenase ABC, approved
by the U.S. Food and Drug Administration for debriding chronic dermal ulcers
and severely burned areas.
35 Wilbur Street Lynbrook,
NY 11563
Phone: (516) 593-7000 Fax:
(516) 593-7010 |
